Dassault Aviation: UCAV: A world first for Dassault

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Dassault Aviation: UCAV: A world first for Dassault Aviation

SAINT-CLOUD, France, April 12, 2014 (GLOBE NEWSWIRE) -- On March 20, 2014, Dassault Aviation organized a formation flight of the nEUROn unmanned combat air vehicle (UCAV) with a Rafale fighter and a Falcon 7X business jet. This was the first time in the world that a combat drone flew in formation with other aircraft. The entire operation lasted 1 hour and 50 minutes and took the patrol out over the Mediterranean to a range of several hundred kilometers.

According to Eric Trappier, Chairman and CEO of Dassault Aviation, "This achievement clearly reflects our expertise in state-of-the-art technologies. Our skills in both military and civil aviation mutually enrich each other, enabling us to design exceptional airplanes suited for both the armed forces and Falcon business jet operators."
                                                                                                                                             
Organizing a formation flight like this was a daunting challenge: for each maneuver in the planned sequence, aircraft from different holding points and with very different characteristics had to fly alongside each other in a confined space.

An additional challenge was being able to control a pilotless aircraft flying near four other aircraft, all manned (Rafale, Falcon 7X and two chase aircraft for photography). Engineers had to plan ahead to take into account the risk of interference, including aerodynamic turbulence between the aircraft, not to mention electromagnetic interference (EMI) with communications between the nEUROn drone and its ground control station.

About nEUROn

nEUROn is a European program for an unmanned combat air vehicle (UCAV) technology demonstrator, conducted by Dassault Aviation as prime contractor under the authority of French defense procurement agency DGA. It heralds tomorrow's defense programs, since it federates expertise from across Europe (France, Italy, Sweden, Spain, Greece and Switzerland). The nEUROn program is designed to validate the development of complex technologies representing all mission systems: high-level flight control and stealth, launching real air-to-ground weapons from an internal bay, integration in the C4I environment, innovative industrial collaboration processes, etc. The demonstrator made its first flight on December 1, 2012, paving the way for a two-year test program. Since then, the nEUROn drone has carried out several dozen test flights.

About Dassault Aviation

With over 8,000 military and civil aircraft delivered to 83 countries over the last 60 years, logging some 28 million hours in flight, Dassault Aviation has built up expertise recognized worldwide in the design, development, sale and support of all types of aircraft, ranging from the Rafale fighter to the high-end Falcon family of business jets and military drones. Dassault Aviation posted sales of 4.59 billion euros in 2013, and has nearly 11,600 employees.

www.dassault-aviation.com
Follow us on Twitter: @Dassault_OnAir

Press Contacts:

Corporate Communication
Stéphane Fort
Tél : +33 (0)1 47 11 86 90
stephane.fort@dassault-aviation.com

Mathieu Durand
Tél : +33 (0)1 47 11 85 88
mathieu.durand@dassault-aviation.com                        

Military Communication

Nathalie Bakhos

Tél : +33 (0)1 47 11 65 11

nathalie.bakhos@dassault-aviation.fr

Falcon CommunicationVadim FeldzerTél : +33 (0)1 47 11 44 13 vadim.feldzer@dassault-aviation.com

For high resolution photos, visit:
http://mediapro.dassault-aviation.com

UCAV: A world first for Dassault Aviation http://hugin.info/143388/R/1776903/606339.pdf

HUG#1776903

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading